Lauren Martz
Executive Director of Biopharma Intelligence at BioCentury, providing analytical deep dives on RNAi, renal disease, neuromuscular and cardiovascular development catalysts.
Best podcasts with Lauren Martz
Ranked by the Snipd community
11 snips
Feb 3, 2026 • 31min
Ep. 348 - Biotech's 2026 Catalysts. Plus: China's New Orphan Rules
Simone Fishburn, geopolitics and life‑sciences policy commentator; Selena Koch, editorial strategist on industry trends; Steve Usdin, policy and regulatory analyst; Lauren Martz, biopharma intelligence lead on RNA and renal. They unpack RNAi and antisense as 2026 catalysts. They cover cardiovascular Lp(a) trials, renal and neuromuscular readouts, obesity launches, and China’s new orphan drug exclusivity rule.
